Select a medication above to begin.
Tolebrutinib
tolebrutinib
Adult Dosing .
Dosage forms: TAB
Investigational New Drug (IND)
- [FDA approval denied, December 2025]
multiple sclerosis
- [FDA approval denied]
- Info: inhibits Bruton tyrosine kinase (BTK), modulating B-cells and activated microglia in the CNS
Peds Dosing .
- Dosage forms: --
Investigational New Drug (IND)
- [FDA approval denied]
- Info: not anticipated to be applicable to Peds population